Berliner Boersenzeitung - Natural immunity more potent than vaccines during US Delta wave: study

EUR -
AED 4.127092
AFN 79.206084
ALL 98.107081
AMD 433.952485
ANG 2.010944
AOA 1030.371405
ARS 1279.21726
AUD 1.742818
AWG 2.02535
AZN 1.906776
BAM 1.95693
BBD 2.278526
BDT 137.109164
BGN 1.956734
BHD 0.423662
BIF 3358.203326
BMD 1.123634
BND 1.460115
BOB 7.814512
BRL 6.345182
BSD 1.128557
BTN 96.362066
BWP 15.270885
BYN 3.693149
BYR 22023.221692
BZD 2.266819
CAD 1.56875
CDF 3225.952428
CHF 0.938156
CLF 0.027556
CLP 1057.429385
CNY 8.100839
CNH 8.117063
COP 4685.552778
CRC 571.032242
CUC 1.123634
CUP 29.776295
CVE 110.328701
CZK 24.87729
DJF 200.956922
DKK 7.460231
DOP 66.498691
DZD 149.22419
EGP 56.230224
ERN 16.854506
ETB 151.981027
FJD 2.544525
FKP 0.846405
GBP 0.841208
GEL 3.07858
GGP 0.846405
GHS 13.881015
GIP 0.846405
GMD 81.467819
GNF 9772.947088
GTQ 8.665042
GYD 236.096316
HKD 8.791417
HNL 29.364085
HRK 7.534303
HTG 147.672491
HUF 402.174928
IDR 18442.144718
ILS 3.978955
IMP 0.846405
INR 96.036809
IQD 1478.353567
IRR 47319.026115
ISK 145.903761
JEP 0.846405
JMD 179.834633
JOD 0.796646
JPY 162.994376
KES 145.802538
KGS 98.261646
KHR 4523.833389
KMF 496.086911
KPW 1011.270384
KRW 1568.306195
KWD 0.345394
KYD 0.940443
KZT 576.372784
LAK 24404.09035
LBP 101113.780727
LKR 338.435405
LRD 225.701319
LSL 20.378366
LTL 3.317798
LVL 0.679675
LYD 6.226623
MAD 10.422618
MDL 19.669357
MGA 5077.954488
MKD 61.543969
MMK 2359.284693
MNT 4015.84413
MOP 9.090649
MRU 44.718018
MUR 51.933998
MVR 17.370832
MWK 1956.83854
MXN 21.70501
MYR 4.820954
MZN 71.799627
NAD 20.378366
NGN 1806.072641
NIO 41.526009
NOK 11.588754
NPR 154.179706
NZD 1.89775
OMR 0.432622
PAB 1.128452
PEN 4.160502
PGK 4.690729
PHP 62.604348
PKR 318.859521
PLN 4.251654
PYG 9014.244726
QAR 4.113275
RON 5.049383
RSD 117.307731
RUB 90.730681
RWF 1616.040255
SAR 4.214677
SBD 9.371587
SCR 15.967185
SDG 674.751766
SEK 10.885039
SGD 1.455696
SHP 0.883
SLE 25.507584
SLL 23562.038366
SOS 644.975264
SRD 40.954763
STD 23256.95022
SVC 9.874701
SYP 14609.330899
SZL 20.372853
THB 37.345123
TJS 11.651879
TMT 3.938336
TND 3.396561
TOP 2.631661
TRY 43.626315
TTD 7.660423
TWD 33.935203
TZS 3016.95637
UAH 46.965025
UGX 4127.383054
USD 1.123634
UYU 47.077391
UZS 14577.416659
VES 105.853295
VND 29163.914236
VUV 136.096828
WST 3.122044
XAF 656.338875
XAG 0.034842
XAU 0.00035
XCD 3.036676
XDR 0.816275
XOF 656.338875
XPF 119.331742
YER 274.285674
ZAR 20.330074
ZMK 10114.048081
ZMW 30.445714
ZWL 361.809612
  • RIO

    -0.2500

    62.39

    -0.4%

  • BTI

    0.9400

    43.58

    +2.16%

  • CMSC

    0.1100

    22.16

    +0.5%

  • NGG

    1.1500

    72.43

    +1.59%

  • SCS

    -0.1500

    10.35

    -1.45%

  • BCC

    -0.7200

    91.19

    -0.79%

  • BCE

    0.0100

    21.57

    +0.05%

  • JRI

    -0.1100

    12.79

    -0.86%

  • RBGPF

    66.9600

    66.96

    +100%

  • RYCEF

    0.0500

    10.96

    +0.46%

  • CMSD

    0.1090

    22.169

    +0.49%

  • BP

    -0.3600

    29.4

    -1.22%

  • RELX

    0.4600

    55.03

    +0.84%

  • VOD

    0.1900

    9.64

    +1.97%

  • GSK

    0.3200

    37.96

    +0.84%

  • AZN

    0.8800

    69.69

    +1.26%

Natural immunity more potent than vaccines during US Delta wave: study
Natural immunity more potent than vaccines during US Delta wave: study

Natural immunity more potent than vaccines during US Delta wave: study

During America's last surge of the coronavirus driven by the Delta variant, people who were unvaccinated but survived Covid were better protected than those who were vaccinated and not previously infected, a new study said Wednesday.

Text size:

The finding is the latest to weigh in on a debate on the relative strengths of natural versus vaccine-acquired immunity against SARS-CoV-2, but comes this time with the imprimatur of the US Centers for Disease Control and Prevention (CDC).

The authors of the paper warned, however, against depending on infection as a strategy, given the higher risks to unvaccinated persons who weren't previously infected of hospitalization, long term impacts, and death, compared to vaccinated people.

Indeed, by November 30, 2021, some 131,000 residents of California and New York had died from Covid-19, the two states the paper, which used statistical modeling, was based on.

"Viruses are constantly changing, including the virus that causes Covid-19," the CDC said in a statement.

"The level of protection offered by vaccination and surviving a previous infection changed during the study period. Vaccination remains the safest strategy for protecting against Covid-19," it added.

The analysis was also carried out before the emergence of the Omicron variant, for which both vaccine and infection-derived immunity appear diminished, and before boosters were made widely available.

It used case data from 1.1 million people who tested positive in New York and California between May 30 to November 30, 2021, and used that to model inferences about the wider population.

Prior to Delta becoming dominant, vaccination conferred greater immunity than infection. But the relationship shifted when the variant became predominant in late June and July.

- Selection bias? -

By the week of October 3, vaccinated people who did not have prior Covid were three to four times (in California and New York, respectively) more likely to be infected than unvaccinated people with prior Covid.

In the weeks of October 13 to November 14, vaccinated people who did not have prior Covid in California, were around three times more likely to be hospitalized than unvaccinated people with prior Covid.

Protection was highest among those who had both vaccination and prior Covid.

The study could however be impacted by an effect known as "selection bias," since it excluded people who died, who were overwhelmingly unvaccinated.

Other research, including a notable paper from Israel in August, have also found that natural immunity was more potent than vaccines during the Delta surge.

But the US CDC had previously taken the opposite position, based on pre-Delta data.

"Further studies are needed to establish duration of protection from previous infection by variant type, severity, and symptomatology, including for the Omicron variant," the paper concluded.

(G.Gruner--BBZ)